Small Molecule Receptor Tyrosine Kinase Inhibitor of Platelet-Derived Growth Factor Signaling (SU9518) Modifies Radiation Response in Fibroblasts and Endothelial Cells

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-6-79
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients With Refractory Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2004English

Editor's Note: Inhibition of Platelet-Derived Growth Factor–mediated Proliferation of Osteosarcoma Cells by the Novel Tyrosine Kinase Inhibitor STI571

Clinical Cancer Research
Cancer ResearchOncology
2019English

Expression of Ligand-Activated KIT and Platelet-Derived Growth Factor Receptor Tyrosine Kinase Receptors in Synovial Sarcoma

Clinical Cancer Research
Cancer ResearchOncology
2004English

Paracrine Interactions of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Endothelial and Lung Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2007English

Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (Gefitinib) Augments Pneumonitis, but Attenuates Lung Fibrosis in Response to Radiation Injury in Rats

Journal of Medical Investigation
BiochemistryMedicineGeneticsMolecular Biology
2012English

The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis

Cancer Research
Cancer ResearchOncology
2008English

Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations: A Prospective Study

Biomedical Journal
Medicine
2015English

Platelet Derived Growth Factor a (PDGFA; PDGF1); Platelet Derived Growth Factor Receptor (PDGFR)

Science-Business eXchange
2011English

Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy